ArticleNature biomedical engineering2026
Liposomal nanoprobes actuated by engineered water channels for sensitive detection of molecular targets by MRI.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Monitoring biochemical processes requires tools to detect specific molecular species in vivo. Although responsive probes detectable by MRI enable this, conventional MRI contrast agents often lack sufficient sensitivity. Here we circumvent this limitation using nanoscale probes constructed from pore-forming peptides incorporated into paramagnetic liposomes. In our design, target molecules control MRI contrast by regulating water access to liposome-encapsulated gadolinium chelators. The large ratio of gadolinium complexes to pores provides a sensitivity gain by over an order of magnitude compared with small-molecule MRI sensors. We demonstrate the probe architecture using biotin as a model analyte and gramicidin A as the basis for responsive pores. We then validate the biotin-sensitive liposomal probes in vitro and in rat brain, and we show that minimally invasive delivery to multiple tissue types is feasible. Furthermore, we identify pore sequences that provide greater MRI contrast effects than native gramicidin and we demonstrate that further channel modifications permit detection of different target molecules. This work thus introduces a potent and engineerable technology for molecular imaging in living systems.
Identifiers
42128908What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.